Alembic Pharma Board Strengthened with New Director

Alembic Pharmaceuticals Limited shareholders have given strong backing to board changes, overwhelmingly approving the appointment of Mr. Rajkumar Baheti as a Non-Executive Non-Independent Director. The postal ballot also secured shareholder approval for the payment of his professional fees.

Voting results showed robust support, with approximately 99.74% of votes cast in favour of his directorship and 99.83% approving the associated fees, indicating significant shareholder confidence in the proposed director and compensation.

This appointment is set to strengthen the company's board with Mr. Baheti's considerable financial and governance expertise, enhancing strategic oversight.

A seasoned Chartered Accountant and Company Secretary, Mr. Baheti brings a wealth of experience in finance, accounts, taxation, and management. He has previously held key financial and executive positions within Alembic group companies, including Director Finance & CFO and Executive Director, providing him deep insight into corporate finance and governance.

In the competitive Indian pharmaceutical sector, where companies like Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, and Cipla also emphasize experienced leadership, such board additions are crucial for navigating regulatory complexities and driving innovation.

With Mr. Baheti now formally inducted, the board's composition is updated. While the filing did not detail specific risks associated with this director appointment, investors will be watching how his financial acumen influences board decisions, the company's ongoing adherence to corporate governance standards, and its performance in key markets like the US.